Lv2
118 积分 2022-07-02 加入
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio
14天前
已完结
Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers
23天前
已完结
Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers
23天前
已完结
Evaluation of Plasma pTau217 plus Abeta42/40, and pTau217/Abeta42 Ratio as Confirmatory Tests for Amyloid Pathology in Alzheimer’s Disease (AD) (N4.003)
1个月前
已关闭
Evaluation of Plasma pTau217 plus Abeta42/40, and pTau217/Abeta42 Ratio as Confirmatory Tests for Amyloid Pathology in Alzheimer’s Disease (AD) (N4.003)
2个月前
已关闭
Head-to-head comparison of diagnostic test accuracy between biparametric and multiparametric MRI: an updated systematic review and bivariate meta-analysis
2个月前
已完结
Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease
2个月前
已完结
The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls
2个月前
已完结
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
2个月前
已完结
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
2个月前
已完结
皖公网安备34019202002308
